Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000899140-18-000218
Filing Date
2018-02-14
Accepted
2018-02-14 14:53:25
Documents
2
Group Members
CUBIST SYSTEMATIC STRATEGIES, LLCPOINT72 CAPITAL ADVISORS, INC.STEVEN A. COHEN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A, AMENDMENT #1 p23743055a.htm SC 13G/A 141325
2 JOINT FILING AGREEMENT p23743055b.htm EX-99.1 6165
  Complete submission text file 0000899140-18-000218.txt   149190
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Subject) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88106 | Film No.: 18611264
SIC: 2834 Pharmaceutical Preparations

Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

EIN.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A